Table 3.
Comparison of the experimental and the control groups at week 8.
| Areas | Peak pressure (kPa) | Maximum force (N) | Contact area (cm2) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| CAFO | PCAFO | P | CAFO | PCAFO | P | CAFO | PCAFO | P | |
| T1 | 129.7±24.3 | 165.5±151.4 | 0.611 | 157.0±48.9 | 126.8±48.9 | 0.312 | 11.5±1.3 | 13.2±9.3 | 0.712 |
| T2–T5 | 50.2±8.4 | 62.5±66.1 | 0.725 | 66.2±34.8 | 43.8±38.7 | 0.723 | 12.1±5.2 | 10.7±7.0 | 0.521 |
| M1 | 140.0±0.8 | 176.5±229.7 | 0.754 | 134.5±50.9 | 97.9±19.7 | 0.322 | 9.3±3.7 | 12.6±7.5 | 0.523 |
| M2 | 204.2±29.4 | 282.5±285.9 | 0.623 | 189.2±69.7 | 177.8±62.3 | 0.841 | 8.8±2.2 | 10.7±6.2 | 0.622 |
| M3 | 408.0±454.9 | 287.2±129.8 | 0.632 | 111.1±65.7 | 233.7±133.9 | 0.223 | 7.3±0.7 | 9.5±5.4 | 0.421 |
| M4 | 174.2±8.7 | 160.7±77.2 | 0.742 | 138.0±25.2 | 138.2±111.8 | 0.912 | 7.6±1.4 | 9.3±5.3 | 0.623 |
| M5 | 109.5±30.3 | 72.2±39.5 | 0.232 | 140.0±60.7 | 82.9±84.1 | 0.332 | 11.8±2.9 | 11.8±7.1 | 0.921 |
| MF | 106.7±9.9 | 62.7±41.2 | 0.114 | 334.5±131.4 | 146.8±162.5 | 0.123 | 29.9±10.8 | 27.5±17.5 | 0.834 |
| MH | 229.2±38.5 | 191.0±100.4 | 0.554 | 303.5±71.0 | 218.4±123.8 | 0.412 | 12.4±3.1 | 14.3±8.5 | 0.723 |
| LH | 215.±3.6 | 227.5±140.4 | 0.832 | 258.2±96.6 | 232.4±155.3 | 0.825 | 11.3±2.7 | 13.1±7.7 | 0.742 |
*
P<0.05 is considered a significant difference; values are expressed as means ± standard deviation;
CAFO – customized AFO; PCAFO – pre-customized AFO; T1 – hallux; T2–T5 – toes 2–5; M1 – first metatarsal; M2 – second metatarsal; M3 – third metatarsal; M4 – fourth metatarsal; M5 – fifth metatarsal; MF – midfoot; MH – medial heel; LH – lateral heel.